Neeraj Agarwal
尼拉杰·阿加瓦尔
MD
Professor of Medicine; Director, Genitourinary Oncology Program医学教授；泌尿生殖肿瘤学项目主任
👥Biography 个人简介
Neeraj Agarwal directs the GU Oncology Program at Huntsman Cancer Institute and has led pivotal trials including ARCHES (enzalutamide in mHSPC) and PROSPER (enzalutamide in nmCRPC). He is a global authority on AR-targeted therapies and novel hormonal agents across prostate cancer disease states.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Enzalutamide Clinical Trials
Principal investigator for ARCHES and PROSPER trials, which established enzalutamide standards of care in metastatic hormone-sensitive and non-metastatic castration-resistant prostate cancer, respectively.
Representative Works 代表性著作
Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer (ARCHES)
Journal of Clinical Oncology (2019)
Phase III trial demonstrating enzalutamide plus ADT significantly reduced risk of radiographic progression or death in mHSPC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 尼拉杰·阿加瓦尔 的研究动态
Follow Neeraj Agarwal's research updates
留下邮箱，当我们发布与 Neeraj Agarwal（Huntsman Cancer Institute, University of Utah）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment